Hook & thesis
Laureate Education has lagged in recent stretches relative to broader markets, but the underlying business profile argues for a contrarian long. The company generates meaningful free cash flow, maintains low financial leverage and is buying back stock. Operational momentum in Latin America plus modest valuation multiples create an attractive risk/reward at current prices.
My thesis: buy LAUR near current levels because cash generation and capital returns are likely to support the stock while enrollment and digital growth offer a multi-quarter catalyst. The position is not a low-volatility trade - expect swings - but the balance sheet and cash flow provide a margin of safety.
Business overview - what Laureate does and why investors should care
Laureate Education operates private higher-education institutions, primarily in Mexico and Peru, delivering undergraduate and graduate programs. The company benefits from demographic tailwinds in Latin America, rising higher-education participation rates and a growing mix of digital learning that can improve margins over time. With headquarters in Miami, Laureate leverages on-the-ground operations in markets where higher-education supply constraints and increasing demand support stable tuition growth and enrollment expansion.
Why the market should care - the fundamental drivers
- Cash generation: Laureate produced free cash flow of $263.6M, giving the company room to fund buybacks and strategic investment without levering up.
- Profitability profile: Return on equity is an attractive 26.66%, evidence that the business converts revenue into shareholder returns effectively.
- Balance sheet health: Debt to equity sits at a conservative 0.21, keeping financial risk limited and allowing management flexibility if macro volatility hits Latin America.
- Capital return program: Management announced a new $100M repurchase program on 09/13/2024, signaling confidence in the long-term cash generation profile and providing direct support for the equity.
Evidence from recent results and market data
Operational updates show steady growth. Reported Q2 2025 revenue of $524.2M was up 5% year-over-year and beat estimates, while another update showed Q3 revenue of $400.2M and management raising full-year revenue guidance to $1.686B (reported 02/13/2026). Those figures point to consistent top-line expansion. The company trades on a market cap of roughly $5.11B and is trading near $36.49 intraday, with a 52-week range of $21.53 to $38.28 (low on 07/31/2025, high on 06/12/2026).
Valuation framing
Laureate's trailing P/E sits around 18-19 (ratios show P/E ~19.18 and earnings-per-share of $2.00), and price-to-sales is about 2.93. EV/EBITDA is roughly 10.34 and enterprise value is about $5.15B. Those multiples are reasonable for a company with mid-single-digit revenue growth and high ROE, particularly given low leverage. Using the company's free cash flow of $263.6M against a market cap near $5.11B implies an FCF yield in the mid-single digits (~5%). That is not cheap, but the yield combined with buybacks and margin expansion potential supports a case for multiple improvement over time.
Technicals and market structure
Price has recovered from last year's lows but remains below the 52-week high, offering room to re-test recent highs. Momentum indicators are mixed: the 10-day SMA is $36.53 while the 50-day SMA is $33.75 and RSI is a healthy 57.6, suggesting some upside remains without being overbought. MACD shows slightly bearish momentum with a small negative histogram, so short-term volatility is likely and prudent risk control is essential. Short interest and short-volume readings are notable; recent settlement data shows short interest around 5.17M shares (06/15/2026) and elevated short-volume days in late June. That dynamic can amplify intraday moves in either direction.
Trade plan (actionable)
Direction: Long
Entry price: Enter at $36.50.
Stop loss: $31.00 (protects against structural downside and keeps loss to a manageable percentage if momentum fails).
Target: $45.00 over a long-term horizon (180 trading days).
Horizon: Long term (180 trading days). I expect the trade to need time to play out because catalysts that will re-rate the multiple - continued enrollment gains, positive margin trends from digital initiatives, and share repurchases - typically take multiple quarters to materialize. If you prefer a staged approach, consider taking partial profits at $40.00 in the mid term (45 trading days) and letting the remainder run toward $45.00.
The stop is sized to limit downside if enrollment or margin trends reverse materially; $31.00 is a level below recent support and preserves capital if negative macro developments in Latin America accelerate. Position sizing should keep the loss at the stop within your risk tolerance - for many retail accounts, that will mean risking a single-digit percentage of portfolio value on this trade.
Catalysts to watch
- Enrollment and revenue prints over the next two quarters - continued sequential improvement in enrollment and revenue beats should re-rate the stock.
- Management execution on digital initiatives and margin expansion, which would increase free cash flow conversion and justify higher multiples.
- Buyback activity - accelerated repurchases beyond the announced $100M program would be an explicit bullish signal and tighten float.
- Analyst upgrades and broader coverage - positive estimate revisions (similar to past Zacks placements) could accelerate multiple expansion.
Risks and counterarguments
Below are the primary risks that could invalidate the thesis, followed by a short counterargument to the bullish case:
- Macroeconomic and currency risk: A deterioration in Latin American economies or sharp currency moves could erode revenue and profit when translated to USD. GAAP earnings have already been impacted by currency translation in past reports.
- Regulatory / political risk: Higher education in Latin America is sensitive to regulation and policy changes. Any adverse regulatory action in core markets could impair enrollment or revenue.
- Execution risk on digital transition: Digital initiatives are a key margin lever. If technology investments fail to scale or student acquisition costs rise, margins could be pressured.
- Volatility from short interest: Elevated short-volume days and non-trivial short interest can lead to sharp intraday moves and whipsaw the position.
- Valuation compression: A broader multiple reset in the market or weaker-than-expected top-line growth could push P/E and EV/EBITDA lower, pressuring the stock even with decent cash flow.
Counterargument: The bear case is straightforward - macro weakness in Latin America or a sustained enrollment slowdown would materially hit the top line and reduce margins, justifying a lower multiple and exposing the company to valuation compression. That scenario is plausible and explains why investors should limit position size and use the stop.
What would change my mind
I would trim or exit the position if: (1) management pauses or reverses buybacks and guidance turns negative; (2) sequential revenue declines or margin erosion appears across two consecutive quarters; (3) debt materially increases (debt/equity rising north of 0.5) or cash flow deteriorates meaningfully below current levels. Conversely, sustained revenue beats and acceleration in free cash flow coupled with accelerated buybacks would reinforce the bullish view.
Conclusion
Laureate presents a compelling asymmetric trade right now: reasonable valuation metrics (P/E ~19, EV/EBITDA ~10.3), healthy free cash flow ($263.6M), low leverage and an active buyback program. Short-term momentum is mixed and short interest is a wildcard, so risk management is essential. For traders comfortable with volatility and willing to give the story 180 trading days, the combination of cash flow and operational growth makes a long entry at $36.50, with a $31 stop and $45 target, a sensible, actionable trade.
Key monitor points:
Watch upcoming revenue prints, margin trajectory, buyback execution and short-interest updates. Any sustained negative trend in those items would force a reassessment.